NU-7441   Click here for help

GtoPdb Ligand ID: 8010

Synonyms: KU-57788 | NU7441
PDB Ligand
Compound class: Synthetic organic
Comment: NU-7441 is a potent and selective, ATP-competitive inhibitor of DNA-dependent protein kinase (DNA-PK) [2]. It is compound 22g in Leahy et al. (2004) [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 0
Rotatable bonds 2
Topological polar surface area 70.92
Molecular weight 413.11
XLogP 7.08
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=c1cc(oc2c1cccc2c1cccc2c1sc1c2cccc1)N1CCOCC1
Isomeric SMILES O=c1cc(oc2c1cccc2c1cccc2c1sc1c2cccc1)N1CCOCC1
InChI InChI=1S/C25H19NO3S/c27-21-15-23(26-11-13-28-14-12-26)29-24-17(6-3-9-20(21)24)19-8-4-7-18-16-5-1-2-10-22(16)30-25(18)19/h1-10,15H,11-14H2
InChI Key JAMULYFATHSZJM-UHFFFAOYSA-N
References
1. Kodama M, Murakami M, Kodama T. (1997)
Differential implications of the oncogene-tumor suppressor gene complex in the geneses of 19 human neoplasias. Evidence in support of the steroid carcinogenesis hypothesis.
Anticancer Res, 17 (3C): 2285-92. [PMID:9216703]
2. Leahy JJ, Golding BT, Griffin RJ, Hardcastle IR, Richardson C, Rigoreau L, Smith GC. (2004)
Identification of a highly potent and selective DNA-dependent protein kinase (DNA-PK) inhibitor (NU7441) by screening of chromenone libraries.
Bioorg Med Chem Lett, 14 (24): 6083-7. [PMID:15546735]
3. Rosenzweig KE, Youmell MB, Palayoor ST, Price BD. (1997)
Radiosensitization of human tumor cells by the phosphatidylinositol3-kinase inhibitors wortmannin and LY294002 correlates with inhibition of DNA-dependent protein kinase and prolonged G2-M delay.
Clin Cancer Res, 3 (7): 1149-56. [PMID:9815794]
4. Smith GC, Jackson SP. (1999)
The DNA-dependent protein kinase.
Genes Dev, 13 (8): 916-34. [PMID:10215620]
5. Smith GCM, Jackson SP. (2003)
Chapter 93 – The PIKK Family of Protein Kinases.  In  Handbook of Cell Signaling Volume 1
Edited by Dennis EA (Academic Press, Elsevier Inc) 557-561. [ISBN:9780121245467]
6. Zhao Y, Thomas HD, Batey MA, Cowell IG, Richardson CJ, Griffin RJ, Calvert AH, Newell DR, Smith GC, Curtin NJ. (2006)
Preclinical evaluation of a potent novel DNA-dependent protein kinase inhibitor NU7441.
Cancer Res, 66 (10): 5354-62. [PMID:16707462]